Renal Tumours Of Non-Clear Cell Histology; 10 Years' Experience In A Specialized Centre.

Q3 Medicine
Yasir Masood, Siddique Adnan, Shaukat Fiaz, Sheheryar Hanif, Zubair Ahmad Cheema, Khurram Mir
{"title":"Renal Tumours Of Non-Clear Cell Histology; 10 Years' Experience In A Specialized Centre.","authors":"Yasir Masood,&nbsp;Siddique Adnan,&nbsp;Shaukat Fiaz,&nbsp;Sheheryar Hanif,&nbsp;Zubair Ahmad Cheema,&nbsp;Khurram Mir","doi":"10.55519/JAMC-02-10703","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Non-clear cell renal cell carcinomas are uncommon renal tumours with diverse histologically and genetically defined entities. Due to limited clinical outcomes data, no standardized management approach can be offered to these patients. This study aimed to analyse outcomes of non clear cell renal cell carcinoma after surgical resection of localized renal tumours in our population.</p><p><strong>Methods: </strong>Patients with renal tumours who underwent partial or radical nephrectomy at the Department of Urology, from January 2010 to December 2019 were identified and evaluated, in terms of prevalence, presentation, recurrence, and survival outcome.</p><p><strong>Results: </strong>Non-clear cell tumours were found in one-fourth of the total number of nephrectomies performed during this period for renal cell carcinoma (RCC). The mean age was 50.48±14.76 years (range 18-89 years) with 57% being of the male gender. The predominant types were chromophobe RCC, papillary RCC, and sarcomatoid RCC, in all non-clear cell renal tumours. Mean Recurrence Free Survival (RFS) for all tumours was 75.26±2.7 months. The projected 5 years RFS of papillary RCC, chromophobe RCC and sarcomatoid RCC were 94.2%, 84.3% and 62.5% respectively.</p><p><strong>Conclusions: </strong>RCC of non-clear-cell histology depicts excellent survival in patients with localized renal tumours. Furthermore, sarcomatoid RCC has worse recurrence free survival followed by chromophobe RCC and papillary RCC, in our population subset.</p>","PeriodicalId":15141,"journal":{"name":"Journal of Ayub Medical College, Abbottabad : JAMC","volume":"35 2","pages":"231-234"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayub Medical College, Abbottabad : JAMC","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55519/JAMC-02-10703","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Non-clear cell renal cell carcinomas are uncommon renal tumours with diverse histologically and genetically defined entities. Due to limited clinical outcomes data, no standardized management approach can be offered to these patients. This study aimed to analyse outcomes of non clear cell renal cell carcinoma after surgical resection of localized renal tumours in our population.

Methods: Patients with renal tumours who underwent partial or radical nephrectomy at the Department of Urology, from January 2010 to December 2019 were identified and evaluated, in terms of prevalence, presentation, recurrence, and survival outcome.

Results: Non-clear cell tumours were found in one-fourth of the total number of nephrectomies performed during this period for renal cell carcinoma (RCC). The mean age was 50.48±14.76 years (range 18-89 years) with 57% being of the male gender. The predominant types were chromophobe RCC, papillary RCC, and sarcomatoid RCC, in all non-clear cell renal tumours. Mean Recurrence Free Survival (RFS) for all tumours was 75.26±2.7 months. The projected 5 years RFS of papillary RCC, chromophobe RCC and sarcomatoid RCC were 94.2%, 84.3% and 62.5% respectively.

Conclusions: RCC of non-clear-cell histology depicts excellent survival in patients with localized renal tumours. Furthermore, sarcomatoid RCC has worse recurrence free survival followed by chromophobe RCC and papillary RCC, in our population subset.

非透明细胞组织学肾肿瘤的研究在专业中心工作10年。
背景:非透明细胞肾细胞癌是一种罕见的肾肿瘤,具有不同的组织学和遗传学特征。由于临床结果数据有限,无法为这些患者提供标准化的管理方法。本研究旨在分析我国人群局部肾肿瘤手术切除后非透明细胞肾细胞癌的预后。方法:对2010年1月至2019年12月在泌尿外科行部分或根治性肾切除术的肾肿瘤患者进行识别和评估,包括患病率、表现、复发和生存结果。结果:非透明细胞肿瘤在此期间肾细胞癌(RCC)手术总数的四分之一被发现。平均年龄50.48±14.76岁(18 ~ 89岁),男性占57%。在所有非透明细胞肾肿瘤中,主要类型为嫌色性肾细胞癌、乳头状肾细胞癌和肉瘤样肾细胞癌。所有肿瘤的平均无复发生存期(RFS)为75.26±2.7个月。乳头状RCC、憎色RCC和肉瘤样RCC的预测5年RFS分别为94.2%、84.3%和62.5%。结论:非透明细胞组织学的肾细胞癌在局部肾肿瘤患者中表现出良好的生存率。此外,在我们的人群中,肉瘤样RCC的无复发生存率较差,其次是憎色性RCC和乳头状RCC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
304
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信